- Home
- MRNA vs CTRA Comparison
MRNA vs CTRA Comparison
Compare MRNA & CTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRNA | CTRA |
|---|---|---|
| Founded | 2010 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 19.6B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MRNA | CTRA |
|---|---|---|
| Price | $50.59 | $33.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 16 |
| Target Price | $34.27 | ★ $35.06 |
| AVG Volume (30 Days) | 5.2M | ★ 6.4M |
| Earning Date | 05-01-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.62% |
| EPS Growth | 21.77 | ★ 49.33 |
| EPS | N/A | ★ 2.24 |
| Revenue | ★ $19,263,000,000.00 | $7,645,000,000.00 |
| Revenue This Year | $9.36 | $15.95 |
| Revenue Next Year | $15.43 | $6.22 |
| P/E Ratio | ★ N/A | $15.04 |
| Revenue Growth | 4.29 | ★ 40.07 |
| 52 Week Low | $22.28 | $22.33 |
| 52 Week High | $59.55 | $36.88 |
Technical Indicators
Market Signals| Indicator | MRNA | CTRA |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 53.56 |
| Support Level | $47.61 | $23.03 |
| Resistance Level | $54.94 | $36.88 |
| Average True Range (ATR) | 2.64 | 1.03 |
| MACD | -0.07 | -0.08 |
| Stochastic Oscillator | 37.52 | 66.94 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CTRA Coterra Energy Inc.
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.